CCR9‐mediated signaling through β‐catenin and identification of a novel CCR9 antagonist

Elevated levels of chemokine receptor CCR9 expression in solid tumors may contribute to poor patient prognosis. In this study, we characterized a novel CCR9‐mediated pathway that promotes pancreatic cancer cell invasion and drug resistance, indicating that CCR9 may play a critical role in cancer pro...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mol Oncol
Glavni autori: Lee, Sangjun, Heinrich, Eileen L., Li, Lily, Lu, Jianming, Choi, Audrey H., Levy, Rachel A., Wagner, Jeffrey E., Yip, M.L. Richard, Vaidehi, Nagarajan, Kim, Joseph
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2015
Teme:
Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512113/
https://ncbi.nlm.nih.gov/pubmed/26003048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.04.012
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items